COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis

Abstract COX-1/PGE2 is an important protective mediator in ulcerative colitis (UC). β-arrestin1 (β-arr1), which acts as a scaffold protein, is involved in PGE2-mediated signaling pathways. However, the interaction between PGE2 and β-arr1 in maintaining mucosal barrier integrity remains unexplored. I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaojie Peng, Jianzhong Li, Siwei Tan, Minyi Xu, Jin Tao, Jie Jiang, Huiling Liu, Bin Wu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d89ca8c8f04e470d989ae71604490efb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d89ca8c8f04e470d989ae71604490efb
record_format dspace
spelling oai:doaj.org-article:d89ca8c8f04e470d989ae71604490efb2021-12-02T16:07:45ZCOX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis10.1038/s41598-017-01169-62045-2322https://doaj.org/article/d89ca8c8f04e470d989ae71604490efb2017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01169-6https://doaj.org/toc/2045-2322Abstract COX-1/PGE2 is an important protective mediator in ulcerative colitis (UC). β-arrestin1 (β-arr1), which acts as a scaffold protein, is involved in PGE2-mediated signaling pathways. However, the interaction between PGE2 and β-arr1 in maintaining mucosal barrier integrity remains unexplored. In this study, we demonstrated that COX-1 and PGE2 were significantly decreased, and EP4 mRNA was downregulated in both UC patients and mice during the injury phase. PGE2 treatment was found to alleviate mucosal injury and induce EP4 expression during dextran sulfate sodium (DSS)-induced colitis in wild-type (WT) mice. Following DSS-induced injury, β-arr1 deficient mice showed increased signs of colitis compared to β-arr1 WT mice, and the expression of PI3K and p-Akt were remarkably downregulated in β-arr1 deficient mice. In parallel, HCT116 cells transfected with β-arr1 siRNA were examined in the presence or absence of PGE2 in vitro. PGE2 treatment in the β-arr1 WT/KO DSS model and β-arr1 siRNA transfection of HCT116 cells confirmed that PGE2 upregulated β-arr1 in vivo and in vitro. Collectively, our results indicate that COX-1/PGE2/EP4 upregulates the β-arr1 mediated Akt signaling pathway to provide mucosal protection in colitis. Thus, these findings provide support for the future development and clinical application of COX-1/PGE2 in UC.Xiaojie PengJianzhong LiSiwei TanMinyi XuJin TaoJie JiangHuiling LiuBin WuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xiaojie Peng
Jianzhong Li
Siwei Tan
Minyi Xu
Jin Tao
Jie Jiang
Huiling Liu
Bin Wu
COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis
description Abstract COX-1/PGE2 is an important protective mediator in ulcerative colitis (UC). β-arrestin1 (β-arr1), which acts as a scaffold protein, is involved in PGE2-mediated signaling pathways. However, the interaction between PGE2 and β-arr1 in maintaining mucosal barrier integrity remains unexplored. In this study, we demonstrated that COX-1 and PGE2 were significantly decreased, and EP4 mRNA was downregulated in both UC patients and mice during the injury phase. PGE2 treatment was found to alleviate mucosal injury and induce EP4 expression during dextran sulfate sodium (DSS)-induced colitis in wild-type (WT) mice. Following DSS-induced injury, β-arr1 deficient mice showed increased signs of colitis compared to β-arr1 WT mice, and the expression of PI3K and p-Akt were remarkably downregulated in β-arr1 deficient mice. In parallel, HCT116 cells transfected with β-arr1 siRNA were examined in the presence or absence of PGE2 in vitro. PGE2 treatment in the β-arr1 WT/KO DSS model and β-arr1 siRNA transfection of HCT116 cells confirmed that PGE2 upregulated β-arr1 in vivo and in vitro. Collectively, our results indicate that COX-1/PGE2/EP4 upregulates the β-arr1 mediated Akt signaling pathway to provide mucosal protection in colitis. Thus, these findings provide support for the future development and clinical application of COX-1/PGE2 in UC.
format article
author Xiaojie Peng
Jianzhong Li
Siwei Tan
Minyi Xu
Jin Tao
Jie Jiang
Huiling Liu
Bin Wu
author_facet Xiaojie Peng
Jianzhong Li
Siwei Tan
Minyi Xu
Jin Tao
Jie Jiang
Huiling Liu
Bin Wu
author_sort Xiaojie Peng
title COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis
title_short COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis
title_full COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis
title_fullStr COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis
title_full_unstemmed COX-1/PGE2/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis
title_sort cox-1/pge2/ep4 alleviates mucosal injury by upregulating β-arr1-mediated akt signaling in colitis
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/d89ca8c8f04e470d989ae71604490efb
work_keys_str_mv AT xiaojiepeng cox1pge2ep4alleviatesmucosalinjurybyupregulatingbarr1mediatedaktsignalingincolitis
AT jianzhongli cox1pge2ep4alleviatesmucosalinjurybyupregulatingbarr1mediatedaktsignalingincolitis
AT siweitan cox1pge2ep4alleviatesmucosalinjurybyupregulatingbarr1mediatedaktsignalingincolitis
AT minyixu cox1pge2ep4alleviatesmucosalinjurybyupregulatingbarr1mediatedaktsignalingincolitis
AT jintao cox1pge2ep4alleviatesmucosalinjurybyupregulatingbarr1mediatedaktsignalingincolitis
AT jiejiang cox1pge2ep4alleviatesmucosalinjurybyupregulatingbarr1mediatedaktsignalingincolitis
AT huilingliu cox1pge2ep4alleviatesmucosalinjurybyupregulatingbarr1mediatedaktsignalingincolitis
AT binwu cox1pge2ep4alleviatesmucosalinjurybyupregulatingbarr1mediatedaktsignalingincolitis
_version_ 1718384748837994496